Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Class I Recall for Supplement Containing Undeclared Drugs
12/20/2023
A Class I recall has been issued for 32,117 bottles of the dietary supplement Dr. Ergin’s SugarMD Advance Glucose Support after an analysis by the US Food and Drug Administration (FDA) identified undeclared metformin and glyburide in the...
A Class I recall has been issued for 32,117 bottles of the dietary supplement Dr. Ergin’s SugarMD Advance Glucose Support after an analysis by the US Food and Drug Administration (FDA) identified undeclared metformin and glyburide in the...
A Class I recall has been issued...
12/20/2023
Pharmacy Learning Network
News
Children’s OTC Med Recalled
12/20/2023
An acetaminophen instability has prompted KinderFarms to voluntarily recall all lots of the over-the-counter (OTC) medication KinderMed Kids’ Pain & Fever. The recall spans nearly 600,000 bottles, according to the December 13, 2023, US Food...
An acetaminophen instability has prompted KinderFarms to voluntarily recall all lots of the over-the-counter (OTC) medication KinderMed Kids’ Pain & Fever. The recall spans nearly 600,000 bottles, according to the December 13, 2023, US Food...
An acetaminophen instability has...
12/20/2023
Pharmacy Learning Network
News
Infant Medicine Recalled for Acetaminophen Instability
12/20/2023
KinderFarms is voluntarily recalling all lots of the over-the-counter (OTC) medication KinderMed Infants’ Pain & Fever due to an acetaminophen instability, according to a November 13, 2023, company announcement.
KinderFarms is voluntarily recalling all lots of the over-the-counter (OTC) medication KinderMed Infants’ Pain & Fever due to an acetaminophen instability, according to a November 13, 2023, company announcement.
KinderFarms is voluntarily...
12/20/2023
Pharmacy Learning Network

Advertisement

News
Medicare Drug Prices Potentially Reduced by 3% Under the Inflation Reduction Act of 2022
12/15/2023
Had the inflationary rebates of the Inflation Reduction Act (IRA) of 2022 been applicable between 2018 and 2020, it could have led to a reduction of around 3% in spending by both patients and the federal government, according to a study...
Had the inflationary rebates of the Inflation Reduction Act (IRA) of 2022 been applicable between 2018 and 2020, it could have led to a reduction of around 3% in spending by both patients and the federal government, according to a study...
Had the inflationary rebates of...
12/15/2023
Pharmacy Learning Network
News
A Metropolitan Monitoring Framework Proposed to Track Opioids in Wastewater
12/15/2023
A new innovative approach for monitoring opioid use and analyzing trends by utilizing wastewater-based epidemiologic methods may help public health officials worldwide manage the opioid epidemic in large metro areas, according to a study...
A new innovative approach for monitoring opioid use and analyzing trends by utilizing wastewater-based epidemiologic methods may help public health officials worldwide manage the opioid epidemic in large metro areas, according to a study...
A new innovative approach for...
12/15/2023
Pharmacy Learning Network
News
Antiemetic Injection Pulled
12/14/2023
More than 6 million vials of ondansetron injection distributed by Baxter Healthcare Corporation are under recall due to failing to meet pH specifications, according to the December 13, 2023, US Food and Drug Administration (FDA) Enforcement...
More than 6 million vials of ondansetron injection distributed by Baxter Healthcare Corporation are under recall due to failing to meet pH specifications, according to the December 13, 2023, US Food and Drug Administration (FDA) Enforcement...
More than 6 million vials of...
12/14/2023
Pharmacy Learning Network

Advertisement

News
Anesthetic Gel Recalled
12/14/2023
The recall affects LET gel (lidocaine 4%/epinephrine 0.18%/tetracaine 0.5%) 3-mL single-use syringes, in 10-syringe packs (NDC 73271-1003-1), from lot 092020237 (Exp. 3/18/24). The syringes were distributed by Carie Boyd Pharmaceuticals,...
The recall affects LET gel (lidocaine 4%/epinephrine 0.18%/tetracaine 0.5%) 3-mL single-use syringes, in 10-syringe packs (NDC 73271-1003-1), from lot 092020237 (Exp. 3/18/24). The syringes were distributed by Carie Boyd Pharmaceuticals,...
The recall affects LET gel...
12/14/2023
Pharmacy Learning Network
News
Overactive Bladder Drug Recalled
12/14/2023
Padagis US is recalling more than 7000 bottles of trospium chloride extended-release capsules for failing to meet capsule specifications. According to the December 13, 2023, US Food and Drug Administration (FDA) Enforcement Report, the...
Padagis US is recalling more than 7000 bottles of trospium chloride extended-release capsules for failing to meet capsule specifications. According to the December 13, 2023, US Food and Drug Administration (FDA) Enforcement Report, the...
Padagis US is recalling more...
12/14/2023
Pharmacy Learning Network
News
Warmer Temperatures Linked to Increased Hospital Visits for Alcohol and Drug Abuse in New York
12/11/2023
Rising outdoor temperatures may influence hospital visits for alcohol and other drugs, according to a study published in Communications Medicine.
Rising outdoor temperatures may influence hospital visits for alcohol and other drugs, according to a study published in Communications Medicine.
Rising outdoor temperatures may...
12/11/2023
Pharmacy Learning Network

Advertisement

News
Supplement Pulled for Containing Undeclared Drug
12/07/2023
According to the December 6, 2023, FDA Enforcement Report, the recall affects all Kuka Flex Forte caplets (UPC 0736640810265), which are packaged in 100-count bottles. The caplets were manufactured by Kukamonga, Guadalajara, Jalisco, Mexico,...
According to the December 6, 2023, FDA Enforcement Report, the recall affects all Kuka Flex Forte caplets (UPC 0736640810265), which are packaged in 100-count bottles. The caplets were manufactured by Kukamonga, Guadalajara, Jalisco, Mexico,...
According to the December 6,...
12/07/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use